ATE110280T1 - Zum wirkort hingeführte und dort angereicherte aktivsubstanzen. - Google Patents
Zum wirkort hingeführte und dort angereicherte aktivsubstanzen.Info
- Publication number
- ATE110280T1 ATE110280T1 AT90909466T AT90909466T ATE110280T1 AT E110280 T1 ATE110280 T1 AT E110280T1 AT 90909466 T AT90909466 T AT 90909466T AT 90909466 T AT90909466 T AT 90909466T AT E110280 T1 ATE110280 T1 AT E110280T1
- Authority
- AT
- Austria
- Prior art keywords
- encouraged
- active substances
- effective site
- substances delivered
- msh4
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title 1
- COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 abstract 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000001441 melanoma Diseases 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/086—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being alphaMSH, alpha melanocyte stimulating hormone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/68—Melanocyte-stimulating hormone [MSH]
- C07K14/685—Alpha-melanotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Endocrinology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898914527A GB8914527D0 (en) | 1989-06-23 | 1989-06-23 | Targetting agents |
| GB909007469A GB9007469D0 (en) | 1990-04-03 | 1990-04-03 | Targetting agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE110280T1 true ATE110280T1 (de) | 1994-09-15 |
Family
ID=26295539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90909466T ATE110280T1 (de) | 1989-06-23 | 1990-06-22 | Zum wirkort hingeführte und dort angereicherte aktivsubstanzen. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0478631B1 (de) |
| JP (1) | JPH04506343A (de) |
| AT (1) | ATE110280T1 (de) |
| AU (1) | AU636365B2 (de) |
| DE (1) | DE69011861T2 (de) |
| DK (1) | DK0478631T3 (de) |
| ES (1) | ES2057572T3 (de) |
| NZ (1) | NZ234173A (de) |
| WO (1) | WO1991000111A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0437487B1 (de) * | 1988-10-04 | 1994-03-09 | Cancer Research Campaign Technology Limited | Zielmittel |
| US5443816A (en) * | 1990-08-08 | 1995-08-22 | Rhomed Incorporated | Peptide-metal ion pharmaceutical preparation and method |
| GB9102450D0 (en) * | 1991-02-05 | 1991-03-20 | Sandoz Ltd | Improvements in or relating to organic compounds |
| US5643549A (en) * | 1992-02-20 | 1997-07-01 | Rhomed Incorporated | Leukostimulatory agent for in vivo leukocyte tagging |
| JPH10509179A (ja) * | 1994-11-17 | 1998-09-08 | アムジエン・インコーポレーテツド | 安定なｎ−末端結合ｄｔｐａ：蛋白質組成物および方法 |
| US5618513A (en) * | 1995-06-07 | 1997-04-08 | Mallinckrodt Medical, Inc. | Method for preparing radiolabeled peptides |
| US7507240B2 (en) | 2005-03-18 | 2009-03-24 | Ron Anthon Olsen | Adjustable splint for osteosynthesis |
| US7717916B2 (en) | 2007-08-16 | 2010-05-18 | Nutek Orthopaedics, Inc. | External fixation apparatus with adjustable pin clamping means |
| US8262657B2 (en) | 2007-08-16 | 2012-09-11 | Nutek Orthopaedics, Inc. | External fixation apparatus with adjustable pin clamping means and convergent bone pins |
| US8123747B2 (en) | 2007-08-16 | 2012-02-28 | Nutek Orthopaedics, Inc. | Apparatus for external fixation of a fractured distal radius with angularly adjustable pin clamping means |
| US8603435B2 (en) | 2008-01-10 | 2013-12-10 | Stc.Unm | Compounds and methods for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same |
| KR100999044B1 (ko) | 2008-03-26 | 2010-12-09 | 한국원자력연구원 | 킬레이트제 접합 α-ＭＳＨ 펩타이드 유도체, 이의제조방법 및 이를 유효성분으로 함유하는 흑색종 진단 및치료용 조성물 |
-
1990
- 1990-06-21 NZ NZ234173A patent/NZ234173A/xx unknown
- 1990-06-22 ES ES90909466T patent/ES2057572T3/es not_active Expired - Lifetime
- 1990-06-22 AT AT90909466T patent/ATE110280T1/de not_active IP Right Cessation
- 1990-06-22 EP EP90909466A patent/EP0478631B1/de not_active Expired - Lifetime
- 1990-06-22 DE DE69011861T patent/DE69011861T2/de not_active Expired - Fee Related
- 1990-06-22 JP JP2508949A patent/JPH04506343A/ja active Pending
- 1990-06-22 WO PCT/GB1990/000966 patent/WO1991000111A1/en not_active Ceased
- 1990-06-22 DK DK90909466.6T patent/DK0478631T3/da active
- 1990-06-22 AU AU58391/90A patent/AU636365B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE69011861T2 (de) | 1995-02-16 |
| EP0478631B1 (de) | 1994-08-24 |
| JPH04506343A (ja) | 1992-11-05 |
| AU636365B2 (en) | 1993-04-29 |
| EP0478631A1 (de) | 1992-04-08 |
| DE69011861D1 (de) | 1994-09-29 |
| ES2057572T3 (es) | 1994-10-16 |
| WO1991000111A1 (en) | 1991-01-10 |
| DK0478631T3 (da) | 1995-04-10 |
| NZ234173A (en) | 1993-10-26 |
| AU5839190A (en) | 1991-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68912302D1 (de) | Härtendes material für medizinischen und dentalen gebrauch. | |
| ATE338771T1 (de) | Antagonisten des intestinotrophen glp-2 peptides | |
| HUP9904023A2 (hu) | Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban | |
| ATE110280T1 (de) | Zum wirkort hingeführte und dort angereicherte aktivsubstanzen. | |
| DE69717788D1 (de) | Komprimierte speicherung eines patientenberichts und wiederaufbau des kompletten textes in implantierbare medizinische vorrichtungen | |
| DE69006628D1 (de) | Pharmazeutische Zusammensetzung, enthaltend Loratadin, Ibuprofen und Pseudoephedrin. | |
| EP0693928A4 (de) | Aminozucker- und glykosaminoglykanzusammensetzung zur behandlung und reparatus von bindegewebe | |
| DE3680924D1 (de) | Metall-radionuklid markiertes protein fuer diagnose und therapie. | |
| ATE106898T1 (de) | Metall-radionuklid-markierte proteine und glykoproteine zur diagnose und therapie. | |
| ATE257386T1 (de) | Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien | |
| FI920664A7 (fi) | Menetelmä hammas- ja sairaanhoidon alalla käytettävien restauraatioide n, proteesien tai vastaavien valmistamiseksi | |
| BR9403783A (pt) | Uso de uma composição cosmética | |
| FI972286A7 (fi) | Uudella tavalla substituoituja DTPA-johdoksia, niiden metallikomplekse ja, kyseisiä komplekseja sisältäviä farmaseuttisia aineita ja niiden k äyttö diagnosoinnissa ja terapiassa | |
| DE69531004D1 (de) | p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES | |
| FR2705558B1 (fr) | Prothèse de reconstruction de hanche et l'appareil de pose. | |
| ATE120091T1 (de) | Vip-konjugate und deren aktive fragmente mit hydrophoben anteilen und topische zuberetungen zur verwendung in der behandlung männlicher impotenz. | |
| DE3875108D1 (de) | Physiologisch aktives polypeptid und pharmazeutische komposition. | |
| DE68928975D1 (de) | Aushärtender Werkstoff für ärztlichen und zahnärztlichen Gebrauch | |
| DE3875866D1 (de) | Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie. | |
| BR9007115A (pt) | Novo trombolitico | |
| TR200000455T2 (tr) | Alzheimer hastalığının tedavisinde fankinonun kullanılması. | |
| IT1241681B (it) | Impianto ortopedico in particolare per l'impiego per la riparazione e/o ricostruzione chirurgica di giunzioni del corpo umano | |
| DE69822810D1 (de) | Somatostatin und somatostatin agoniste zur behandlung der insulinsunempfindlichkeit und syndrome x | |
| EP0988316A4 (de) | Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind. | |
| KR100488038B1 (ko) | 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |